← FDA Drug Approvals (Drugs@FDA)

SIMVASTATIN

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: YILING · Approved 2024-11-27

Drug application

FDA Application #

ANDA211394

Application type

Abbreviated New Drug Application (Generic)

Brand name

SIMVASTATIN

Generic name

SIMVASTATIN

Active ingredients

SIMVASTATIN

Dosage form

TABLET

Route

ORAL

Marketing status

Prescription

Sponsor

YILING

Manufacturer

Westminster Pharmaceuticals, LLC

First approval

2024-11-27

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown